Reduction of parathyoid hormone levels

Research output: Patent

Standard

Reduction of parathyoid hormone levels. / Hartmann, Bolette (Inventor); B. Henriksen, Dennis (Inventor).

Patent No.: US2010/0081,622. Apr 01, 2011.

Research output: Patent

Harvard

Hartmann, B & B. Henriksen, D Apr. 01 2011, Reduction of parathyoid hormone levels, Patent No. US2010/0081,622.

APA

Hartmann, B., & B. Henriksen, D. (2011). Reduction of parathyoid hormone levels. (Patent No. US2010/0081,622).

Vancouver

Hartmann B, B. Henriksen D, inventors. Reduction of parathyoid hormone levels. US2010/0081,622. 2011 Apr 1.

Author

Hartmann, Bolette (Inventor) ; B. Henriksen, Dennis (Inventor). / Reduction of parathyoid hormone levels. Patent No.: US2010/0081,622. Apr 01, 2011.

Bibtex

@misc{a1d4d7a2b78540c8a934745f4c00b176,
title = "Reduction of parathyoid hormone levels",
abstract = "A method of acutely reducing the plasma level of PTH of a patient having an elevated PTH comprising the administration of a pharmaceutical composition comprising a GLP-2, or a variant, an analogue, or derivative of GLP-2 having the ability to bind and activate a GLP-2 receptor such as GLP-2 1-34",
keywords = "Faculty of Health and Medical Sciences",
author = "Bolette Hartmann and {B. Henriksen}, Dennis",
year = "2011",
month = apr,
day = "1",
language = "English",
type = "Patent",
note = "US2010/0081,622",

}

RIS

TY - PAT

T1 - Reduction of parathyoid hormone levels

AU - Hartmann, Bolette

AU - B. Henriksen, Dennis

PY - 2011/4/1

Y1 - 2011/4/1

N2 - A method of acutely reducing the plasma level of PTH of a patient having an elevated PTH comprising the administration of a pharmaceutical composition comprising a GLP-2, or a variant, an analogue, or derivative of GLP-2 having the ability to bind and activate a GLP-2 receptor such as GLP-2 1-34

AB - A method of acutely reducing the plasma level of PTH of a patient having an elevated PTH comprising the administration of a pharmaceutical composition comprising a GLP-2, or a variant, an analogue, or derivative of GLP-2 having the ability to bind and activate a GLP-2 receptor such as GLP-2 1-34

KW - Faculty of Health and Medical Sciences

M3 - Patent

M1 - US2010/0081,622

Y2 - 2009/09/28

ER -

ID: 34206222